Drug Controller General Of India Rsquo

Rediff.com » News » Drug Controller General Of India Rsquo

News for Drug Controller General Of India Rsquo

News
Business

Does India have enough vaccine reserves to combat another Covid wave?

Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......

India probes four cough syrups after 66 Gambian children's deaths

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially......

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator, reports Sohini......

Millions of Covid vaccine doses are set to expire in India

Pune-based Serum Institute of India (SII) is sitting on 200 million doses of Covishield that were manufactured in December and are set to expire in September. The company is likely to destroy......

SIIto test Novavax's Omicron-specific vaccine

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for ‘examination, test, and analysis’,......

Pharma cos okay with QR codes to combat counterfeit drugs

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say......

What is Schedule M and why it's mandatory for all pharma units

With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will......

Pharma companies fight fakes with smart packaging

Indian pharmaceutical companies are stepping up their efforts to combat the problem of counterfeit drugs, employing a variety of strategies, from packaging innovations to engaging private......

How govt plans to ensure faster availability of new drugs

Given the stringent nature of India’s regulatory environment for clinical trials, several pharmaceutical companies have moved their trials out of India. As a result, only 1.2 per cent of......

Regulatory woes torpedo PE/VC deals in e-pharma sector

With regulatory uncertainties clouding the future of online pharmacies, deals in the space are showing signs of slowdown, as also fresh investment from private-equity (PE) firms and venture......

Rediff News

Drug Controller General Of India Rsquo

News for Drug Controller General Of India Rsquo

Does India have enough vaccine reserves to combat another Covid wave?

India probes four cough syrups after 66 Gambian children's deaths

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

Millions of Covid vaccine doses are set to expire in India

SIIto test Novavax's Omicron-specific vaccine

Pharma cos okay with QR codes to combat counterfeit drugs

What is Schedule M and why it's mandatory for all pharma units

Pharma companies fight fakes with smart packaging

How govt plans to ensure faster availability of new drugs

Regulatory woes torpedo PE/VC deals in e-pharma sector

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS